ArticleFrontiers in molecular biosciences2021

Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response.

Wen Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.